Antidepressant and statin interactions: a review and case report of simvastatin and nefazodone-induced rhabdomyolysis and transaminitis.
Karnik
Niranjan S
NS
Department of Psychiatry, and Behavioral Sciences, Stanford University School of Medicine, CA 94305, USA. nkarnik@stanford.edu
Maldonado
José R
JR
D000368:Aged; D000928:Antidepressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology* / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy; D004347:Drug Interactions; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D010879:Piperazines; D012206:Rhabdomyolysis / Q000139:chemically induced*; D019821:Simvastatin / Q000009:adverse effects* / Q000627:therapeutic use; D000637:Transaminases / Q000097:blood / Q000378:metabolism*; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use
D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D000960:Hypolipidemic Agents; D010879:Piperazines; D014230:Triazoles; C051752:nefazodone; D019821:Simvastatin; D000637:Transaminases